Enanta Pharmaceuticals (ENTA) Other Gross PP&E Adjustments (2016 - 2025)
Historic Other Gross PP&E Adjustments for Enanta Pharmaceuticals (ENTA) over the last 14 years, with Q3 2025 value amounting to $8.7 million.
- Enanta Pharmaceuticals' Other Gross PP&E Adjustments rose 24600.16% to $8.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.7 million, marking a year-over-year increase of 24600.16%. This contributed to the annual value of $8.7 million for FY2025, which is 24600.16% up from last year.
- Per Enanta Pharmaceuticals' latest filing, its Other Gross PP&E Adjustments stood at $8.7 million for Q3 2025, which was up 24600.16% from $19.6 million recorded in Q2 2025.
- In the past 5 years, Enanta Pharmaceuticals' Other Gross PP&E Adjustments registered a high of $19.6 million during Q2 2025, and its lowest value of -$36.0 million during Q1 2024.
- For the 5-year period, Enanta Pharmaceuticals' Other Gross PP&E Adjustments averaged around -$7.4 million, with its median value being -$7.7 million (2021).
- As far as peak fluctuations go, Enanta Pharmaceuticals' Other Gross PP&E Adjustments crashed by 27701.84% in 2022, and later soared by 24600.16% in 2025.
- Enanta Pharmaceuticals' Other Gross PP&E Adjustments (Quarter) stood at -$19.4 million in 2021, then decreased by 21.32% to -$23.5 million in 2022, then rose by 9.33% to -$21.3 million in 2023, then soared by 176.98% to $16.4 million in 2024, then crashed by 46.8% to $8.7 million in 2025.
- Its last three reported values are $8.7 million in Q3 2025, $19.6 million for Q2 2025, and $18.1 million during Q1 2025.